RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jayalakshmi Sridhar to Receptor, erbB-2

Back to Details
This is a "connection" page, showing publications Jayalakshmi Sridhar has written about Receptor, erbB-2.
Jayalakshmi Sridhar
Connection Strength
0.869
Receptor, erbB-2
  1. Schroeder RL, Stevens CL, Sridhar J. Small molecule tyrosine kinase inhibitors of ErbB2/HER2/Neu in the treatment of aggressive breast cancer. Molecules. 2014 Sep 23; 19(9):15196-212.
    View in: PubMed
    Score: 0.447
  2. Sridhar J, Sfondouris ME, Bratton MR, Nguyen TL, Townley I, Klein Stevens CL, Jones FE. Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer. Bioorg Med Chem Lett. 2014 Jan 01; 24(1):126-31.
    View in: PubMed
    Score: 0.422
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support